Literature DB >> 11796625

In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.

Hinda J Ahmed1, Catharina Johansson, Liselott A Svensson, Karin Ahlman, Margareta Verdrengh, Teresa Lagergård.   

Abstract

We investigated the phagocytosis of Haemophilus ducreyi both in vitro and in vivo. Human granulocyte and monocyte phagocytosis of opsonized and nonopsonized, fluorescence-labeled H. ducreyi was assessed by flow cytometry. Both Escherichia coli and noncapsulated H. influenzae were included as controls. The maximal percentage of granulocytes taken up by H. ducreyi was 35% after 90 min. In contrast, 95% of H. influenzae bacteria were phagocytosed by granulocytes after 30 min. These results indicated that H. ducreyi phagocytosis was slow and inefficient. Bacterial opsonization by using specific antibodies increased the percentage of granulocytes phagocytosing H. ducreyi from 24 to 49%. The nonphagocytosed bacteria were completely resistant to phagocytosis even when reexposed to granulocytes, indicating that the H. ducreyi culture comprised a mixture of phenotypes. The intracellular survival of H. ducreyi in granulocytes, in monocytes/macrophages, and in a monocyte cell line (THP-1) was quantified after application of gentamicin treatment to kill extracellular bacteria. H. ducreyi survival within phagocytes was poor; approximately 11 and <0.1% of the added bacteria survived intracellularly after 2 and 20 h of incubation, respectively, while no intracellular H. influenzae bacteria were recovered after 2 h of incubation with phagocytes. The role of phagocytes in the development of skin lesions due to H. ducreyi was also studied in vivo. Mice that were depleted of granulocytes and/or monocytes and SCID mice, which lacked T and B cells, were injected intradermally with approximately 10(6) CFU of H. ducreyi. Within 4 days of inoculation, the granulocyte-depleted mice developed lesions that persisted throughout the experimental period. This result reinforces the importance of granulocytes in the early innate defense against H. ducreyi infection. In conclusion, H. ducreyi is insufficiently phagocytosed to achieve complete eradication of the bacteria. Indeed, H. ducreyi has the ability to survive intracellularly for short periods within phagocytic cells in vitro. Since granulocytes play a major role in the innate defense against H. ducreyi infection in vivo, bacterial resistance to phagocytosis probably plays a crucial role in the pathogenesis of chancroid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796625      PMCID: PMC127673          DOI: 10.1128/IAI.70.2.899-908.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Periplasmic copper-zinc superoxide dismutase protects Haemophilus ducreyi from exogenous superoxide.

Authors:  L R San Mateo; M M Hobbs; T H Kawula
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

2.  Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  GroEL heat shock protein of Haemophilus ducreyi: association with cell surface and capacity to bind to eukaryotic cells.

Authors:  A Frisk; C A Ison; T Lagergård
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Monoclonal antibodies against Haemophilus ducreyi lipooligosaccharide and their diagnostic usefulness.

Authors:  H J Ahmed; S Borrelli; J Jonasson; L Eriksson; S Hanson; B Höjer; M Sunkuntu; E Musaba; E L Roggen; T Lagergård
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

5.  Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.

Authors:  H J Ahmed; A Frisk; J E Månsson; E K Schweda; T Lagergård
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Alterations in levels of DnaK and GroEL result in diminished survival and adherence of stressed Haemophilus ducreyi.

Authors:  L M Parsons; R J Limberger; M Shayegani
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

7.  Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.

Authors:  A Frisk; H J Ahmed; E Van Dyck; T Lagergård
Journal:  Microb Pathog       Date:  1998-08       Impact factor: 3.738

8.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 9.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  A diffusible cytotoxin of Haemophilus ducreyi.

Authors:  L D Cope; S Lumbley; J L Latimer; J Klesney-Tait; M K Stevens; L S Johnson; M Purven; R S Munson; T Lagergard; J D Radolf; E J Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

View more
  13 in total

1.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

4.  Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling.

Authors:  Jason R Mock; Merja Vakevainen; Kaiping Deng; Jo L Latimer; Jennifer A Young; Nicolai S C van Oers; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Haemophilus ducreyi LspA proteins are tyrosine phosphorylated by macrophage-encoded protein tyrosine kinases.

Authors:  Kaiping Deng; Jason R Mock; Steven Greenberg; Nicolai S C van Oers; Eric J Hansen
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

6.  Effector prediction in host-pathogen interaction based on a Markov model of a ubiquitous EPIYA motif.

Authors:  Shunfu Xu; Chao Zhang; Yi Miao; Jianjiong Gao; Dong Xu
Journal:  BMC Genomics       Date:  2010-12-01       Impact factor: 3.969

7.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Authors:  Tricia L Humphreys; Lang Li; Xiaoman Li; Diane M Janowicz; Kate R Fortney; Qianqian Zhao; Wei Li; Jeanette McClintick; Barry P Katz; David S Wilkes; Howard J Edenberg; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

10.  Mechanism of human natural killer cell activation by Haemophilus ducreyi.

Authors:  Wei Li; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.